Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zhai

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 17, 2021
[The effect of CYP3A5 gene polymorphism on tacrolimus concentration and adverse events in patients undergoing allogeneic hematopoietic stem cell transplantation]X Chen, R L Zhang, W H Zhai, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 14, 2022
[Preclinical study of T cell receptor specifically reactive with <i>KRAS</i> G12V mutation in the treatment of malignant tumors]X J Cheng, D Jiang, L H Zhang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|March 16, 2026
[Clinical efficacy and safety of eculizumab in pediatric atypical hemolytic uremic syndrome]J Chen, C Y Wang, J J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Analysis of risk factors of relapse after allogeneic hematopoietic stem cell transplantation in patients with t (8;21) acute myeloid leukemia]W W Guo, X Liu, A M Pang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 6, 2018
[Outcome of acute myeloid leukemia with FLT3-ITD mutation treated by allogeneic hematopoietic stem cell transplantation]C Liang, E L Jiang, J F Yao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 17, 2021
[Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis]H X Zhang, A M Pang, X Chen, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 30, 2018
RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathyZhen Liang, Kai P Gao, Yi X Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 1, 2024
[Analysis of therapeutic effects of allogeneic hematopoietic stem cell transplantation in 12 patients with DEK-NUP214 fusion gene positive acute myeloid leukemia]Y Y Shen, D L Yang, Y He, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 5, 2022
[Efficacy of basiliximab in the treatment of 87 cases of steroid-refractory or steroid-dependent acute graft-versus-host disease]Z X He, R L Zhang, W H Zhai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation]X Chen, Z Y Liu, R L Zhang, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 17, 2021
[The effect of CYP3A5 gene polymorphism on tacrolimus concentration and adverse events in patients undergoing allogeneic hematopoietic stem cell transplantation]X Chen, R L Zhang, W H Zhai, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 14, 2022
[Preclinical study of T cell receptor specifically reactive with <i>KRAS</i> G12V mutation in the treatment of malignant tumors]X J Cheng, D Jiang, L H Zhang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|March 16, 2026
[Clinical efficacy and safety of eculizumab in pediatric atypical hemolytic uremic syndrome]J Chen, C Y Wang, J J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Analysis of risk factors of relapse after allogeneic hematopoietic stem cell transplantation in patients with t (8;21) acute myeloid leukemia]W W Guo, X Liu, A M Pang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 6, 2018
[Outcome of acute myeloid leukemia with FLT3-ITD mutation treated by allogeneic hematopoietic stem cell transplantation]C Liang, E L Jiang, J F Yao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 17, 2021
[Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis]H X Zhang, A M Pang, X Chen, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 30, 2018
RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathyZhen Liang, Kai P Gao, Yi X Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 1, 2024
[Analysis of therapeutic effects of allogeneic hematopoietic stem cell transplantation in 12 patients with DEK-NUP214 fusion gene positive acute myeloid leukemia]Y Y Shen, D L Yang, Y He, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 5, 2022
[Efficacy of basiliximab in the treatment of 87 cases of steroid-refractory or steroid-dependent acute graft-versus-host disease]Z X He, R L Zhang, W H Zhai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation]X Chen, Z Y Liu, R L Zhang, et al.
Pageof 18